SCYNEXIS Inc SCYX

RE:RE:RE:RE:BREXAFEMME - published User side effects

[JonathanJSmith]

I'm disgusted too. What does $45MM get them, another quarter's worth of financing - maybe two? One would think that they'd do a financing AFTER their sNDA submittal. I guess they successfully managed to get their buddies on board, on the cheap. You're right, it's another fleecing of retail investors; it makes me wonder whether I'll waste my time with biotechs in the future - most seem to bilk shareholders for billions.

I, too, DCA'd. Now I'm seling the covered calls. Somebody else can buy the dream. Based on current fundamentals, the stock is still relatively inexpensive. I suspect we'll be over $3 in short order - especially when they submit their sNDA.

Perhaps, next year they can acquire a 30sec SuperBowl ad spot; it's probably worth the $6MM since they blow that kind of money in a heartbeat anyway. At least millions of women will hear about Brexafemme. Give Coyne and Amplity six or so more months to deliver; otherwise, fire them.

Even Tags talks the big talk. In the last CC, he mentioned that the franchise should deliver $700MM-$800MM in US sales alone. Hmmmm, if he's remotely close, this stock could still be a big boon to investors who get on board now. I'm hesitant to buy additional shares since I don't trust management as much as I used to; notwithstanding, the smart (and unemotional) thing to do is to load up now, and sell quickly on any reasonable pop; at least I can recouperate some of my current losses. Like the Great Gazoo said, "if you can't afford to lose, you can't afford to win!"

Alas, such are the vicissitudes of investing.

Cheers and good luck,

JJ